Trial, By Desire: One FQHC’s Research Trial Experience RE: COVID-19 Vaccine

Trial, By Desire: One FQHC’s Research Trial Experience RE: COVID-19 Vaccine


Publication Date: January 27, 2021


Description

The CEO of HealthLinc, Inc, a FQHC in Indiana. Beth Wrobel shares her recent experience in the Johnson & Johnson COVID-19 vaccine trial as a health center CEO at HealthLinc, LLC., a vaccine trial site, and her personal experience as a trial participant. This interview was conducted as part of NACHC’s Leadership Development Technical Assistance Program.

Download the document.

Questions? Contact us at trainings@nachc.org.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.